DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
DarioHealth Corp. (DRIO)
NASDAQ:AMEX Investor Relations:
dariohealth.com/our-story
Company Research
Source: PR Newswire
Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core B2B2C revenue increased.2023 B2B2C, employers and health plans recurring revenues increased 39% year over year as the core business continues to gain traction.Commercial revenues in 2023 generated majority of the revenue with B2B2C growing from 13% to 25% of total revenue from 2022 to 2023.GAAP operating expenses decreased by 11.2% sequentially from the third quarter of 2023.Non-GAAP operating expenses decreased 9.4% sequentially from the third quarter to $9.9M. Signed multiple customers onto the Aetna platform which subsequently launched in Q1 of 2024.Saw significant interest and multiple employer adoption of the Dario GLP-1 Behavioral Change Program as well as expansions of current customer relationships on the metabolic side.Enhanced path to profitability through improvements across the financial profile on an annual basi
Show less
Read more
Impact Snapshot
Event Time:
DRIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRIO alerts
High impacting DarioHealth Corp. news events
Weekly update
A roundup of the hottest topics
DRIO
News
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes [Yahoo! Finance]Yahoo! Finance
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical OutcomesPR Newswire
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 SolutionPR Newswire
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health [Yahoo! Finance]Yahoo! Finance
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral HealthPR Newswire
DRIO
Earnings
- 11/2/23 - Beat
DRIO
Sec Filings
- 4/22/24 - Form S-3
- 4/22/24 - Form 8-K
- 4/19/24 - Form PRE
- DRIO's page on the SEC website